AlphaValue/Baader Europe on Monday downgraded its recommendation on medical technology company Getinge (GETI-B.ST) to add from buy and kept the price target at 276 kronor.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)